Shashikant Kulkarni
Overview
Explore the profile of Shashikant Kulkarni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
8417
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Desrosiers-Battu L, Lee J, Tarasiewicz I, Gilbert A, Galvan E, Singh A, et al.
Cancer Genet
. 2025 Feb;
292-293:106-110.
PMID: 39985924
Meningiomas are the most common primary brain tumors in adults but much less frequent in children. Many subtypes exist, including anaplastic (malignant) meningioma, which accounts for less than 20% of...
2.
Desrosiers-Battu L, Wang T, Reuther J, Miles G, Dai H, Jo E, et al.
JCO Precis Oncol
. 2024 Sep;
8():e2400187.
PMID: 39259914
Purpose: To evaluate the relative diagnostic yield of clinical germline genomic tests in a diverse pediatric cancer population. Patients And Methods: The KidsCanSeq study enrolled pediatric cancer patients across six...
3.
Wigby K, Brockman D, Costain G, Hale C, Taylor S, Belmont J, et al.
NPJ Genom Med
. 2024 Feb;
9(1):15.
PMID: 38409289
Early use of genome sequencing (GS) in the diagnostic odyssey can reduce suffering and improve care, but questions remain about which patient populations are most amenable to GS as a...
4.
Horak P, Griffith M, Danos A, Pitel B, Madhavan S, Liu X, et al.
Genet Med
. 2022 Sep;
24(9):1991.
PMID: 36063163
No abstract available.
5.
Austin-Tse C, Jobanputra V, Perry D, Bick D, Taft R, Venner E, et al.
NPJ Genom Med
. 2022 Apr;
7(1):27.
PMID: 35395838
Whole genome sequencing (WGS) shows promise as a first-tier diagnostic test for patients with rare genetic disorders. However, standards addressing the definition and deployment practice of a best-in-class test are...
6.
Horak P, Griffith M, Danos A, Pitel B, Madhavan S, Liu X, et al.
Genet Med
. 2022 Feb;
24(5):986-998.
PMID: 35101336
Purpose: Several professional societies have published guidelines for the clinical interpretation of somatic variants, which specifically address diagnostic, prognostic, and therapeutic implications. Although these guidelines for the clinical interpretation of...
7.
Huselton E, Rettig M, Fletcher T, Ritchey J, Gehrs L, McFarland K, et al.
Leuk Lymphoma
. 2021 Jan;
62(6):1441-1449.
PMID: 33467957
Interactions between the bone marrow microenvironment and MDS tumor clones play a role in pathogenesis and response to treatment. We hypothesized G-CSF and plerixafor may enhance sensitivity to azacitidine in...
8.
Marshall C, Chowdhury S, Taft R, Lebo M, Buchan J, Harrison S, et al.
NPJ Genom Med
. 2020 Oct;
5:47.
PMID: 33110627
Whole-genome sequencing (WGS) has shown promise in becoming a first-tier diagnostic test for patients with rare genetic disorders; however, standards addressing the definition and deployment practice of a best-in-class test...
9.
Marshall C, Bick D, Belmont J, Taylor S, Ashley E, Dimmock D, et al.
Genome Med
. 2020 May;
12(1):48.
PMID: 32460895
Clinical whole-genome sequencing (WGS) offers clear diagnostic benefits for patients with rare disease. However, there are barriers to its widespread adoption, including a lack of standards for clinical practice. The...
10.
Evenson M, Cai C, Hucthagowder V, McNulty S, Neidich J, Kulkarni S, et al.
Cancer Genet
. 2019 Dec;
240:66-72.
PMID: 31794935
Ependymomas are neuroepithelial tumors that differentiate along the ependymal cell lineage, a lining of the ventricles of the brain and the central canal of the spinal cord. They are rare...